Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Glycogen Synthase Kinase 3β Inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-Oxime Enhances Drug Resistance to 5-Fluorouracil Chemotherapy in Colon Cancer Cells.

Liu KP, Luo F, Xie SM, Tang LJ, Chen MX, Wu XF, Zhong XY, Zhao T.

Chin J Cancer Res. 2012 Jun;24(2):116-23. doi: 10.1007/s11670-012-0116-9.

2.

Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.

Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, Schwartz JH, Borkan SC.

Am J Physiol Renal Physiol. 2005 Apr;288(4):F703-13. Epub 2004 Nov 30.

3.

6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.

Xingi E, Smirlis D, Myrianthopoulos V, Magiatis P, Grant KM, Meijer L, Mikros E, Skaltsounis AL, Soteriadou K.

Int J Parasitol. 2009 Oct;39(12):1289-303. doi: 10.1016/j.ijpara.2009.04.005. Epub 2009 May 13.

PMID:
19445946
4.

Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.

Wang FS, Ko JY, Weng LH, Yeh DW, Ke HJ, Wu SL.

Life Sci. 2009 Nov 4;85(19-20):685-92. doi: 10.1016/j.lfs.2009.09.009. Epub 2009 Sep 25.

PMID:
19782693
6.

Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.

Yeste-Velasco M, Folch J, Trullàs R, Abad MA, Enguita M, Pallàs M, Camins A.

Neuropharmacology. 2007 Aug;53(2):295-307. Epub 2007 May 26.

PMID:
17612578
7.

Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.

Obama K, Kanai M, Kawai Y, Fukushima M, Takabayashi A.

Int J Oncol. 2002 Aug;21(2):309-14.

PMID:
12118326
8.

Correlation of GOLPH3 Gene with Wnt Signaling Pathway in Human Colon Cancer Cells.

Qiu CZ, Wang MZ, Yu WS, Guo YT, Wang CX, Yang XF.

J Cancer. 2016 May 7;7(8):928-34. doi: 10.7150/jca.13968. eCollection 2016.

9.
10.
12.

C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.

Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.

Cancer Gene Ther. 2002 May;9(5):453-63.

14.

Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.

Tsuchiya K, Nakamura T, Okamoto R, Kanai T, Watanabe M.

Gastroenterology. 2007 Jan;132(1):208-20. Epub 2006 Oct 21.

PMID:
17241872
15.

Inhibitors of GSK-3 prevent corticosterone from inducing COX-1 expression in cardiomyocytes.

Sun H, Chen QM.

Cardiovasc Toxicol. 2008 Summer;8(2):93-100. doi: 10.1007/s12012-008-9018-y. Epub 2008 Jun 27.

PMID:
18584335
16.

Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.

McGinn CJ, Pestalozzi BC, Drake JC, Glennon MC, Kunugi K, Otterson G, Allegra CJ, Johnston PG, Kinsella TJ.

Cancer J. 2000 Jul-Aug;6(4):234-42.

PMID:
11038143
17.
18.

Expression and function of glycogen synthase kinase-3 in human hair follicles.

Yamauchi K, Kurosaka A.

Arch Dermatol Res. 2010 May;302(4):263-70. doi: 10.1007/s00403-009-0987-x. Epub 2009 Aug 25.

PMID:
19705135
19.

Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.

Ischenko I, Camaj P, Seeliger H, Kleespies A, Guba M, De Toni EN, Schwarz B, Graeb C, Eichhorn ME, Jauch KW, Bruns CJ.

Oncogene. 2008 Dec 4;27(57):7212-22. doi: 10.1038/onc.2008.326. Epub 2008 Sep 15.

PMID:
18794807
20.

Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.

Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T.

Genes Cells. 1998 Jun;3(6):395-403.

Supplemental Content

Support Center